dihydrotestosterone has been researched along with Hypergonadotropic Hypogonadism in 111 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 39 (35.14) | 18.7374 |
| 1990's | 21 (18.92) | 18.2507 |
| 2000's | 27 (24.32) | 29.6817 |
| 2010's | 18 (16.22) | 24.3611 |
| 2020's | 6 (5.41) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, W; Kallel, A; López, FJ; Marschke, KB; Martinborough, E; Motamedi, M; Negro-Vilar, A; Shen, Y; van Oeveren, A; West, S; Zhao, S; Zhi, L | 1 |
| Chang, WY; Lau, TL; Long, YO; López, FJ; Marschke, KB; Martinborough, E; Negro-Vilar, A; Oeveren, Av; Rix, PJ; Shen, Y; Vajda, EG; Viveros, OH; Zhi, L | 1 |
| Bracken, K; Conway, AJ; Desai, R; Grossmann, M; Handelsman, DJ; Inder, WJ; Jesudason, D; Ly, LP; Shankara-Narayana, N; Stuckey, BGA; Wittert, GA; Yeap, BB | 1 |
| Aguilar-Riera, C; Camats-Tarruella, N; Canestrino, G; Clemente, M; Fernández-Alvarez, P; Yeste, D | 1 |
| Carmeliet, G; Claessens, F; D'Haese, P; David, K; Deboel, L; Decallonne, B; Dubois, V; Evenepoel, P; Moermans, K; Schollaert, D; Sommers, V; Vanderschueren, D; Verhulst, A | 1 |
| Gittelman, M; Jaffe, JS; Kaminetsky, JC | 1 |
| Baccini, M; Bartolomeo, N; Carbone, MD; De Pergola, G; Di Dalmazi, G; Fanelli, F; Giagulli, VA; Pagotto, U; Pasquali, R; Pelusi, C; Triggiani, V | 1 |
| Antonio, L; Claessens, F; Corbeels, K; David, K; Deboel, L; Decallonne, B; Dubois, V; Gustafsson, JÅ; Khalil, R; Kim, NR; Ohlsson, C; Schollaert, D; Van der Schueren, B; Vanderschueren, D; Vangoitsenhoven, R | 1 |
| Dugas, M; Isidori, AM; Kliesch, S; Sandhowe-Klaverkamp, R; Sansone, A; Schlatt, S; Zitzmann, M | 1 |
| Cohen, B; McMahon, CG; Shusterman, N | 1 |
| Conway, A; Curtis, D; Goebel, C; Handelsman, DJ; Jayadev, V; Lim, S; Savkovic, S; Turner, L | 1 |
| Ascoli, M; Matzkin, ME; Yamashita, S | 1 |
| Corbo, GM; Di Marco Berardino, A; Inchingolo, R; Mancini, A; Raimondo, S; Smargiassi, A; Valente, S | 1 |
| Brailly-Tabard, S; Fiet, J; Giton, F; Le Bouc, Y; Maione, L; Sarfati, J; Trabado, S; Young, J | 1 |
| De Toni, L; Di Nisio, A; Ferlin, A; Foresta, C; Rocca, MS; Speltra, E; Taglialavoro, G | 1 |
| Carrara, D; Efros, M; Neijber, A | 1 |
| Buckley, MJ; Harrison, RW; Wittert, GA; Wlodarczyk, J | 1 |
| Gleeson, HK; Shalet, SM | 1 |
| Gooren, LJ; Haide, A; Saad, F; Yassin, A | 1 |
| Boonen, S; Bouillon, R; Callewaert, F; Ophoff, J; Vanderschueren, D; Venken, K | 1 |
| Abel, MH; De Gendt, K; Monteiro, A; O'Shaughnessy, PJ; Verhoeven, G | 1 |
| Barrett-Connor, E; Bergstrom, J; Lakin, C; Palazzi-Churas, K; Parsons, JK; Trifiro, MD | 1 |
| Friedman, AE | 1 |
| Araujo, AB; Wittert, GA | 1 |
| Baron, S; Brailly-Tabard, S; Bry-Gauillard, H; Chanson, P; Galland, F; Guiochon-Mantel, A; Maione, L; Pitteloud, N; Salenave, S; Sinisi, AA; Trabado, S; Young, J | 1 |
| Goldenberg, SL; Koupparis, A; Robinson, ME | 1 |
| Blankenstein, MA; Bui, HN; Heijboer, AC; Meuleman, EJ; van der Sluis, TM; van Moorselaar, RJ; Vis, AN | 1 |
| Bartfai, G; Boonen, S; Bouillon, R; Casanueva, FF; Finn, JD; Forti, G; Giwercman, A; Han, TS; Huhtaniemi, IT; Kula, K; Lean, ME; Lee, DM; O'Neill, TW; Pendleton, N; Punab, M; Pye, SR; Tajar, A; Vanderschueren, D; Wu, FC | 1 |
| Allan, CM; Foo, CF; McCabe, MJ; McTavish, KJ; Nicholls, PK; Stanton, PG | 1 |
| Arai, S; Hashimoto, K; Honma, S; Ito, K; Kashiwagi, B; Miyashiro, Y; Nakamura, Y; Sasano, H; Sekine, Y; Shibata, Y; Suzuki, K; Tomaru, Y; Uei, T | 1 |
| Adams, BD; Callaghan, JJ; Handa, RJ; Hendrix, MJ; Khalkhali-Ellis, Z; Price, RH | 1 |
| Bullmann, C; Jockenhövel, F; Krone, W; Minnemann, T; Reiners, C; Schubert, M | 1 |
| Bélanger, A; Bélanger, MC; Julien, P; Labrie, C; Labrie, F; Leblanc, M; Tchernof, A | 1 |
| Bouloux, PM; Cullen, D; Grossman, AB; Korbonits, M; Reincke, M; Ross, RJ; Schneider, H; Slawik, M; Stalla, G | 1 |
| Cunningham, G; Dobs, AS; Friedman, TC; Katznelson, L; Kipnes, M; Levine, HL; Matsumoto, AM; Snyder, P; Swerdloff, R; Wang, C; Weber, TJ | 1 |
| Nowotny, P; Vierhapper, H; Waldhäusl, W | 1 |
| Byrne, M; Gerss, J; Köpcke, W; Kühnert, B; Lemmnitz, G; Nieschlag, E; Simoni, M | 1 |
| Qoubaitary, A; Swerdloff, RS; Wang, C | 1 |
| Brennan, K; Handelsman, DJ; Seibel, MJ; Sims, NA; Spaliviero, J | 1 |
| Bell, D; Cosgrove, M; Eilers, B; Fischer, J; Mazer, N; Wu, J | 1 |
| Berlin, K; Bloch, M; Kevala, KR; Kim, HY; Rubinow, DR; Schmidt, PJ | 1 |
| Bostwick, DG; Dorey, FJ; Epstein, JI; Hess, DL; Macairan, ML; Makarov, DV; Marks, LS; Mazer, NA; Mostaghel, E; Nelson, PS; Partin, AW; Veltri, RW | 1 |
| Saad, F; Yassin, AA | 1 |
| Augès, M; Bunouf, P; Fiet, J; Legros, JJ; Raynaud, JP; Rollet, J; Sournac, M | 1 |
| Licea-Perez, H; Szapacs, ME; Wang, S; Yang, E | 1 |
| Gibson, C; Haq, N; Negro, PP; Rubinow, DR; Schmidt, PJ; Steinberg, EM | 1 |
| Lagoguey, M; Mowszowicz, I; Renoir, M; Schaison, G | 1 |
| Duckett, GE; Reiter, EO; Root, AW | 1 |
| Anderson, DC; Cantrill, JA; Dewis, P; Large, DM; Newman, M | 1 |
| Deucher, R; Fukushima, DK; Kream, J; Levin, J; Rosenfeld, RS; Strain, GW; Strain, JJ; Zumoff, B | 1 |
| Davidson, JM; Greenleaf, WJ; Kwan, M | 1 |
| Bancroft, J; Davidson, DW; Skakkebaek, NE; Warner, P | 1 |
| Joplin, GF; Kelly, WF; Kjeld, JM; Mashiter, K | 1 |
| Brerault, JL; Chemana, D; Fiet, J; Morville, R; Passa, P; Tabuteau, F; Villette, JM | 1 |
| Dash, RJ; Lamba, PS; Sialy, R | 1 |
| Cain, MP; Husmann, DA | 1 |
| Crawford, BA; Handelsman, DJ; Simpson, JM; Singh, J | 1 |
| Alexander, G; Berman, N; Davidson, T; Dudley, RE; McDonald, V; Salehian, B; Swerdloff, RS; Wang, C; Ziel, F | 1 |
| Arver, S; Dobs, AS; Mazer, NA; Meikle, AW; Rajaram, L; Sanders, SW | 1 |
| Jockenhövel, F; Kreutzer, M; Lederbogen, S; Reinhardt, W; Reinwein, D; Vogel, E | 1 |
| Alexander, G; Barstow, TJ; Berman, N; Clark, R; Davidson, T; Dudley, RE; Eyre, DR; Iranmanesh, A; Kleinberg, D; Newman, C; Sinow, R; Swerdloff, RS; Veldhuis, J; Wang, C | 1 |
| Jockenhövel, F; Reinhardt, W; Reinwein, D; Vogel, E | 1 |
| Blum, WF; Englaro, P; Jockenhövel, F; Krone, W; Müller-Wieland, D; Rascher, W; Reinwein, D; Vogel, E | 1 |
| Castro, R; Legon, C; Li, GR; Ludot, T; Tostain, J | 1 |
| Atkinson, L; Winters, SJ | 1 |
| Allen, R; Chen, MC; Dobs, AS; Hoover, DR | 1 |
| Arver, S; Caramelli, KE; Dobs, AS; Mazer, NA; Meikle, AW; Rajaram, L; Sanders, SW | 1 |
| Behre, HM; Dressendörfer, RA; Nieschlag, E; Strasburger, CJ; Tschöp, M | 1 |
| Swerdloff, RS; Wang, C | 1 |
| Behre, HM; Kliesch, S; Nieschlag, E; von Eckardstein, S | 1 |
| Abshagen, K; Behre, HM; Büchter, D; Nieschlag, E; Simoni, M; Von Eckardstein, S | 1 |
| Kung, AW; Shiu, SW; Tan, KC | 1 |
| Berman, N; Chuapoco, B; Dudley, RE; Faulkner, S; Hull, L; Longstreth, JA; Steiner, B; Swerdloff, RS; Wang, C | 1 |
| Asscheman, H; Gooren, LJ | 1 |
| Berman, N; Cunningham, G; Dobs, A; Iranmanesh, A; Longstreth, J; Matsumoto, AM; Snyder, PJ; Swerdloff, RS; Wang, C; Weber, T | 1 |
| Arver, S; Bachorik, PS; Caramelli, KE; Dobs, AS; Mazer, NA; Meikle, AW; Sanders, SW | 1 |
| Clark, JC; Daniell, HW; Dunn, SR; Ferguson, DW; Figueroa, ML; Niazi, ZA; Pereira, SE; Stratte, PT | 1 |
| Franchimont, P; Kicovic, PM; Mattei, A; Roulier, R | 1 |
| Stahl, F | 1 |
| Caminos-Torres, R; Ma, L; Snyder, PJ | 1 |
| Loriaux, DL; Sherins, RJ; Winters, SJ | 1 |
| Leone, G; Petrosino, L | 1 |
| Bundschu, HD; Hayduk, K; Heller, S; Liebau, G; Lüders, G; Pfeiffer, EH; Rager, K | 1 |
| Abbasi, AA; Congco, E; Oberleas, D; Ortega, J; Prasad, AS | 1 |
| Vermeulen, A | 1 |
| Hosaka, M | 1 |
| Arimura, A; Kastin, AJ; Schally, AV | 1 |
| Coert, A; Hirschhäuser, C; Hopkinson, CR; Sturm, G | 1 |
| Bricaire, H; Mahoudeau, JA; Valcke, JC | 1 |
| Kuttenn, F; Mauvais-Jarvis, P | 1 |
| Cappellini, A; Forti, G; Pazzagli, M; Serio, M | 1 |
| Bricaire, H; Mahoudeau, JA | 1 |
| Mazer, NA; Meikle, AW; Moellmer, JF; Odell, WD; Sanders, SW; Stringham, JD; Tolman, KG | 1 |
| Dudley, RE; Stuenkel, CA; Yen, SS | 1 |
| Cunningham, GR; Hirshkowitz, M; Karacan, I; Korenman, SG | 1 |
| Findlay, JC; Place, V; Snyder, PJ | 1 |
| Cordero, E; Cunningham, GR; Thornby, JI | 1 |
| Adler, RA; Deiss, WP; Farrell, ME; Krieg, RJ | 1 |
| Díaz-Sánchez, V; Garza-Flores, J; Larrea, F; Richards, E; Ulloa-Aguirre, A; Veayra, F | 1 |
| Bals-Pratsch, M; Langer, K; Nieschlag, E; Place, VA | 1 |
| Ahmed, SR; Bartholomew, M; Boucher, AE; Demers, LM; Manni, A; Santen, RJ | 1 |
| Burris, AS; Ewing, LL; Sherins, RJ | 1 |
| Gooren, LJ | 1 |
| Niermann, H; Schulz, H | 1 |
| Besser, GM; Fisher, RA; McNeilly, AS; Mortimer, CH; Murray, MA | 1 |
| Barnes, EW; Irvine, WJ; Ismail, AA | 1 |
| Concolino, G; Marocchi, A; Sciarra, F; Sorcini, G | 1 |
| Gold, NI; Jan, W | 1 |
| Bercovici, JP; Crepy, Q; Mauvais-Jarvis, P | 1 |
| Hamilton, CR; Kliman, B | 1 |
| Bercovici, JP; Floch, HH; Mauvais-Jarvis, P | 1 |
7 review(s) available for dihydrotestosterone and Hypergonadotropic Hypogonadism
| Article | Year |
|---|---|
Endocrinology of the aging male.
Topics: Aging; Animals; Dehydroepiandrosterone; Dihydrotestosterone; Follicle Stimulating Hormone; Humans; Hypogonadism; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Male; Sex Hormone-Binding Globulin; Testis; Testosterone | 2011 |
Differing levels of testosterone and the prostate: a physiological interplay.
Topics: Animals; Dihydrotestosterone; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Prostate; Prostatic Neoplasms; Testosterone | 2011 |
Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer.
Topics: 5-alpha Reductase Inhibitors; Adult; Androgen Antagonists; Contraindications; Dihydrotestosterone; Gonadotropin-Releasing Hormone; Humans; Hypogonadism; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 2012 |
Advances in male hormone substitution therapy.
Topics: Age Factors; Androgen Receptor Antagonists; Androgens; Clinical Trials as Topic; Contraindications; Dihydrotestosterone; Drug Delivery Systems; Drug Monitoring; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Testosterone | 2005 |
[Treatment of erectile disorders with androgens: When? How?].
Topics: Algorithms; Decision Trees; Dihydrotestosterone; Drug Monitoring; Erectile Dysfunction; Humans; Hypogonadism; Male; Patient Selection; Testosterone | 1997 |
Dihydrotestosterone: a rationale for its use as a non-aromatizable androgen replacement therapeutic agent.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aged; Aging; Dihydrotestosterone; Gels; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Middle Aged | 1998 |
[The determination, secretion and plasma concentration of androgens].
Topics: Adolescent; Adult; Age Factors; Androgen Antagonists; Androgen-Binding Protein; Androgens; Androstane-3,17-diol; Androstenedione; Child; Dehydroepiandrosterone; Dihydrotestosterone; Female; Humans; Hypogonadism; Infant; Male; Pregnancy; Radioimmunoassay; Sex Factors; Testosterone; Virilism | 1979 |
34 trial(s) available for dihydrotestosterone and Hypergonadotropic Hypogonadism
| Article | Year |
|---|---|
Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections.
Topics: Aged; Cohort Studies; Diabetes Mellitus, Type 2; Dihydrotestosterone; Follicle Stimulating Hormone; Follow-Up Studies; Genitalia, Male; Glucose Intolerance; Humans; Hypogonadism; Injections; Luteinizing Hormone; Male; Middle Aged; Quality of Life; Recovery of Function; Sexual Behavior; Testosterone; Withholding Treatment | 2022 |
Safety of a New Subcutaneous Testosterone Enanthate Auto-Injector: Results of a 26-Week Study.
Topics: Adolescent; Adult; Aged; Blood Pressure Monitoring, Ambulatory; Dihydrotestosterone; Estradiol; Hormone Replacement Therapy; Humans; Hypogonadism; Injections; Male; Middle Aged; Prostate-Specific Antigen; Reproducibility of Results; Testosterone; Young Adult | 2019 |
Effect of clomiphene citrate treatment on the Sertoli cells of dysmetabolic obese men with low testosterone levels.
Topics: Adult; Anti-Mullerian Hormone; Clomiphene; Cross-Over Studies; Diabetes Mellitus, Type 2; Dihydrotestosterone; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Antagonists; Follow-Up Studies; Humans; Hypoglycemic Agents; Hypogonadism; Inhibins; Male; Metabolic Syndrome; Metformin; Middle Aged; Obesity; Sertoli Cells; Testosterone | 2020 |
Pharmacokinetics, Clinical Efficacy, Safety Profile, and Patient-Reported Outcomes in Patients Receiving Subcutaneous Testosterone Pellets 900 mg for Treatment of Symptoms Associated With Androgen Deficiency.
Topics: Adolescent; Adult; Aged; Dihydrotestosterone; Drug Implants; Estradiol; Humans; Hypogonadism; Male; Middle Aged; Patient Reported Outcome Measures; Patient Satisfaction; Penile Erection; Prospective Studies; Surveys and Questionnaires; Testosterone; Treatment Outcome; Young Adult | 2017 |
The efficacy, bioavailability and safety of a novel hydroalcoholic testosterone gel 2% in hypogonadal men: results from phase II open-label studies.
Topics: Adolescent; Adult; Aged; Biological Availability; Dihydrotestosterone; Gels; Humans; Hypogonadism; Male; Middle Aged; Testosterone; Treatment Outcome; Young Adult | 2016 |
An open-label, phase 2, single centre, randomized, crossover design bioequivalence study of AndroForte 5 testosterone cream and Testogel 1% testosterone gel in hypogonadal men: study LP101.
Topics: Administration, Cutaneous; Adult; Aged; Androgens; Cross-Over Studies; Dihydrotestosterone; Estradiol; Follicle Stimulating Hormone; Gels; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Sex Hormone-Binding Globulin; Skin Cream; Testosterone; Therapeutic Equivalency | 2016 |
Effect of aromatizable and unaromatizable androgen replacement in hypogonadal men on GH responsiveness.
Topics: Adult; Androgens; Dihydrotestosterone; Hormone Replacement Therapy; Human Growth Hormone; Humans; Hypogonadism; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Male; Middle Aged; Recombinant Proteins; Testosterone | 2009 |
Decline of plasma 5alpha-dihydrotestosterone (DHT) levels upon testosterone administration to elderly men with subnormal plasma testosterone and high DHT levels.
Topics: Aging; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Humans; Hypogonadism; Male; Middle Aged; Testosterone | 2008 |
Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism.
Topics: Adult; Aged; Androgens; Bone Density; Dihydrotestosterone; Double-Blind Method; Drug Implants; Estradiol; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Mesterolone; Middle Aged; Osteoporosis; Prospective Studies; Steroids; Testosterone | 2003 |
A comparison of a novel testosterone bioadhesive buccal system, striant, with a testosterone adhesive patch in hypogonadal males.
Topics: Administration, Buccal; Adult; Androgens; Dihydrotestosterone; Drug Delivery Systems; Humans; Hypogonadism; Male; Middle Aged; Osmolar Concentration; Testosterone; Tissue Adhesives | 2004 |
New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men.
Topics: Adult; Aged; Aging; Androgens; Body Mass Index; Cheek; Dihydrotestosterone; Drug Administration Schedule; Drug Delivery Systems; Estradiol; Follicle Stimulating Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Mouth Mucosa; Osmolar Concentration; Patient Acceptance of Health Care; Patient Compliance; Testosterone; Tissue Adhesives | 2004 |
Production rates of cortisol in men with hypogonadism.
Topics: Adult; Aging; Body Mass Index; Chromatography, High Pressure Liquid; Dihydrotestosterone; Gas Chromatography-Mass Spectrometry; Humans; Hydrocortisone; Hypogonadism; Kinetics; Male; Middle Aged; Testosterone | 2004 |
Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trial.
Topics: Administration, Cutaneous; Adult; Aged; Androgens; Dihydrotestosterone; Estradiol; Follicle Stimulating Hormone; Gels; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Patient Dropouts; Prostate; Prostate-Specific Antigen; Scrotum; Surveys and Questionnaires; Testosterone | 2005 |
Comparison of the steady-state pharmacokinetics, metabolism, and variability of a transdermal testosterone patch versus a transdermal testosterone gel in hypogonadal men.
Topics: Administration, Cutaneous; Adult; Aged; Androgens; Cross-Over Studies; Dihydrotestosterone; Estradiol; Gels; Humans; Hypogonadism; Male; Middle Aged; Testosterone; Therapeutic Equivalency | 2005 |
Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
Topics: Adult; Age of Onset; Aged; Biopsy, Needle; Dihydrotestosterone; Double-Blind Method; Epithelial Cells; Gene Expression Profiling; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Prostate; Prostatic Neoplasms; RNA; Testosterone | 2006 |
Plasma levels of dihydrotestosterone remain in the normal range in men treated with long-acting parenteral testosterone undecanoate.
Topics: Aged; Azasteroids; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Testosterone | 2007 |
Efficacy and safety of a new testosterone-in-adhesive matrix patch applied every 2 days for 1 year to hypogonadal men.
Topics: Adhesiveness; Adhesives; Administration, Cutaneous; Adolescent; Adult; Aged; Androstenedione; Biological Availability; Delayed-Action Preparations; Dihydrotestosterone; Drug Administration Schedule; Drug Delivery Systems; Drug Tolerance; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Prostate-Specific Antigen; Safety; Testosterone; Time Factors | 2008 |
Pharmacologically induced hypogonadism and sexual function in healthy young women and men.
Topics: Adult; Affect; Dihydrotestosterone; Estradiol; Female; Humans; Hypogonadism; Leuprolide; Male; Middle Aged; Orgasm; Progesterone; Sex Characteristics; Sexual Behavior; Sexual Dysfunction, Physiological; Testosterone | 2009 |
Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study.
Topics: Adult; Clinical Trials as Topic; Dihydrotestosterone; Double-Blind Method; Estradiol; Humans; Hypogonadism; Male; Middle Aged; Sex Hormone-Binding Globulin; Sexual Behavior; Testosterone | 1981 |
Pharmacokinetics and metabolism of a permeation-enhanced testosterone transdermal system in hypogonadal men: influence of application site- -a clinical research center study.
Topics: Administration, Cutaneous; Adult; Aged; Biological Availability; Cross-Over Studies; Dihydrotestosterone; Estradiol; Follicle Stimulating Hormone; Humans; Hypogonadism; Kinetics; Luteinizing Hormone; Male; Metabolic Clearance Rate; Middle Aged; Testosterone | 1996 |
Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.
Topics: Administration, Sublingual; Adult; Anthropometry; Body Composition; Bone Remodeling; Bone Resorption; Dihydrotestosterone; Estradiol; Humans; Hypogonadism; Male; Middle Aged; Muscles; Progesterone; Sex; Testosterone | 1996 |
Effects of various modes of androgen substitution therapy on erythropoiesis.
Topics: Adult; Dihydrotestosterone; Drug Implants; Erythropoiesis; Ferritins; Hematocrit; Hemoglobins; Humans; Hypogonadism; Iron; Male; Mesterolone; Regression Analysis; Testosterone; Testosterone Congeners | 1997 |
Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men.
Topics: Adult; Body Mass Index; Dihydrotestosterone; Estradiol; Humans; Hypogonadism; Leptin; Male; Proteins; Regression Analysis; Sex Hormone-Binding Globulin; Testosterone | 1997 |
Pharmacokinetic characteristics, efficacy, and safety of buccal testosterone in hypogonadal males: a pilot study.
Topics: Administration, Buccal; Adult; Aged; Dihydrotestosterone; Double-Blind Method; Estradiol; Humans; Hypogonadism; Male; Middle Aged; Pilot Projects; Placebos; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 1998 |
Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.
Topics: Administration, Cutaneous; Adult; Aged; Dermatitis, Contact; Dihydrotestosterone; Estradiol; Humans; Hypogonadism; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Testosterone | 1997 |
A time-resolved fluorescence immunoassay for the measurement of testosterone in saliva: monitoring of testosterone replacement therapy with testosterone buciclate.
Topics: Adult; Dihydrotestosterone; Estradiol; Female; Fluoroimmunoassay; Humans; Hypogonadism; Male; Middle Aged; Radioimmunoassay; Saliva; Sensitivity and Specificity; Sex Hormone-Binding Globulin; Testosterone | 1998 |
Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men.
Topics: Adult; Analysis of Variance; Body Weight; Dihydrotestosterone; Ejaculation; Estradiol; Hormone Replacement Therapy; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Sex Hormone-Binding Globulin; Testosterone | 1999 |
Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study.
Topics: Administration, Cutaneous; Adult; Cross-Over Studies; Dihydrotestosterone; Estradiol; Female; Gels; Hormone Replacement Therapy; Humans; Hypogonadism; Middle Aged; Testosterone | 2000 |
[Scrotal testosterone patches: a good addition to therapeutic options for hypogonadal men].
Topics: Administration, Cutaneous; Adult; Dihydrotestosterone; Follow-Up Studies; Hormone Replacement Therapy; Humans; Hypogonadism; Libido; Male; Middle Aged; Patient Dropouts; Scrotum; Sex; Testosterone; Treatment Outcome | 2000 |
Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.
Topics: Administration, Cutaneous; Adult; Aged; Biological Availability; Dihydrotestosterone; Estradiol; Gels; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Patient Compliance; Sex Hormone-Binding Globulin; Testosterone | 2000 |
Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system.
Topics: Administration, Cutaneous; Adult; Aged; Aging; Anthropometry; Cholesterol; Dihydrotestosterone; Estradiol; Gonadal Steroid Hormones; Humans; Hypogonadism; Lipoproteins; Lipoproteins, HDL; Male; Middle Aged; Sex Hormone-Binding Globulin; Testosterone | 2001 |
[Depot mesterolone in the management of male hypogonadism].
Topics: Clinical Trials as Topic; Delayed-Action Preparations; Dihydrotestosterone; Drug Evaluation; Humans; Hypogonadism; Male; Mesterolone | 1976 |
Testosterone undecanoate: a new orally active androgen.
Topics: 17-Ketosteroids; Administration, Oral; Adult; Androgens; Clinical Trials as Topic; Dihydrotestosterone; Fatty Acids; Humans; Hypogonadism; Male; Placebos; Stimulation, Chemical; Testosterone | 1975 |
Substitution therapy of hypogonadal men with transdermal testosterone over one year.
Topics: Administration, Cutaneous; Adult; Clinical Trials as Topic; Dihydrotestosterone; Follicle Stimulating Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; Scrotum; Testosterone; Time Factors | 1988 |
70 other study(ies) available for dihydrotestosterone and Hypergonadotropic Hypogonadism
| Article | Year |
|---|---|
Novel selective androgen receptor modulators: SAR studies on 6-bisalkylamino-2-quinolinones.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Animals; Binding, Competitive; Dihydrotestosterone; Genitalia, Male; Hypogonadism; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Models, Molecular; Molecular Conformation; Orchiectomy; Organ Size; Organ Specificity; Prostate; Quinolines; Rats; Receptors, Androgen; Structure-Activity Relationship; Transfection | 2007 |
Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulators.
Topics: Administration, Oral; Anabolic Agents; Androgen Receptor Antagonists; Androgens; Animals; Biological Availability; Bone Density Conservation Agents; Female; Humans; Hypogonadism; Male; Muscle, Skeletal; Organ Size; Osteoporosis, Postmenopausal; Prostate; Pyrrolidines; Quinolines; Quinolones; Rats; Stereoisomerism; Structure-Activity Relationship | 2007 |
A New
Topics: Dihydrotestosterone; DNA-Binding Proteins; Humans; Hypogonadism; Hypospadias; Luteinizing Hormone; Male; Nuclear Proteins; Testis; Testosterone; Transcription Factors | 2022 |
Androgen therapy does not prevent bone loss and arterial calcifications in male rats with chronic kidney disease.
Topics: Adenine; Androgens; Animals; Bone Diseases, Metabolic; Dihydrotestosterone; Hypogonadism; Male; Rats; Renal Insufficiency, Chronic; Testosterone | 2023 |
Testosterone Reduces Body Fat in Male Mice by Stimulation of Physical Activity Via Extrahypothalamic ERα Signaling.
Topics: Adipose Tissue; Animals; Dihydrotestosterone; Energy Metabolism; Estrogen Receptor alpha; Hypogonadism; Hypothalamus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Motor Activity; Obesity; Physical Conditioning, Animal; Signal Transduction; Testosterone; Testosterone Congeners | 2021 |
Serum concentrations of dihydrotestosterone are associated with symptoms of hypogonadism in biochemically eugonadal men.
Topics: Aged; Aging; Body Mass Index; Cross-Sectional Studies; Dihydrotestosterone; Erectile Dysfunction; Geriatric Assessment; Humans; Hypogonadism; Male; Middle Aged; Surveys and Questionnaires; Symptom Assessment; Testosterone | 2021 |
Urine and Serum Sex Steroid Profile in Testosterone-Treated Transgender and Hypogonadal and Healthy Control Men.
Topics: Adolescent; Adult; Androgens; Androsterone; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Estrogens; Estrone; Humans; Hypogonadism; Luteinizing Hormone; Male; Mass Spectrometry; Middle Aged; Testosterone; Transgender Persons; Transsexualism; Young Adult | 2018 |
The ERK1/2 pathway regulates testosterone synthesis by coordinately regulating the expression of steroidogenic genes in Leydig cells.
Topics: Androgens; Androstenedione; Animals; Cells, Cultured; Cholesterol; Dihydrotestosterone; Gene Expression; Genotype; Hypogonadism; Leydig Cells; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; MAP Kinase Signaling System; Mice; Mice, Knockout; Progesterone; Testosterone; Transcription Factors; Transcription, Genetic | 2013 |
Serum level of testosterone, dihydrotestosterone and IGF-1 during an acute exacerbation of COPD and their relationships with inflammatory and prognostic indices: a pilot study.
Topics: Aged; APACHE; Biomarkers; Dihydrotestosterone; Disease Progression; Female; Humans; Hypogonadism; Inflammation; Insulin-Like Growth Factor I; Male; Pilot Projects; Prognosis; Pulmonary Disease, Chronic Obstructive; Reference Values; Serum Amyloid A Protein; Testosterone | 2014 |
Sex steroids, precursors, and metabolite deficiencies in men with isolated hypogonadotropic hypogonadism and panhypopituitarism: a GCMS-based comparative study.
Topics: Adult; Androstenedione; Chromatography, Gas; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Estrone; Humans; Hypogonadism; Hypopituitarism; Male; Mass Spectrometry; Progesterone; Testosterone; Young Adult | 2015 |
Regulation of Sclerostin Production in Human Male Osteocytes by Androgens: Experimental and Clinical Evidence.
Topics: Adaptor Proteins, Signal Transducing; Adult; Androgens; Blotting, Western; Bone Morphogenetic Proteins; Case-Control Studies; Cells, Cultured; Dihydrotestosterone; Fluorescent Antibody Technique; Follicle Stimulating Hormone; Gene Expression Regulation; Gene Knockdown Techniques; Genetic Markers; Humans; Hypogonadism; In Vitro Techniques; Luteinizing Hormone; Male; Osteocytes; Osteoporosis; Parathyroid Hormone; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Testosterone; Young Adult | 2015 |
Sex steroids during bone growth: a comparative study between mouse models for hypogonadal and senile osteoporosis.
Topics: Absorptiometry, Photon; Aging; Amino Acids; Animals; Bone Development; Dihydrotestosterone; Disease Models, Animal; Estradiol; Gonadal Steroid Hormones; Hormone Replacement Therapy; Hypogonadism; Male; Mice; Orchiectomy; Osteocalcin; Osteoporosis; Phenotype; Tomography, X-Ray Computed | 2009 |
Occurrence of testicular microlithiasis in androgen insensitive hypogonadal mice.
Topics: Androgens; Animals; Cryptorchidism; Dihydrotestosterone; Disease Models, Animal; Female; Gonadotropins; Humans; Hypogonadism; Lithiasis; Male; Mice; Mice, Knockout; Receptors, Androgen; Sertoli Cells; Testicular Diseases; Testis; Testosterone | 2009 |
Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men.
Topics: California; Dihydrotestosterone; Epidemiologic Methods; Humans; Hypogonadism; Independent Living; Male; Middle Aged; Prostatic Hyperplasia; Prostatism; Testosterone | 2010 |
Testosterone may speed up the growth of prostate cancer due to aromatase activity.
Topics: Androgens; Dihydrotestosterone; Humans; Hypogonadism; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone | 2010 |
Estradiol levels in men with congenital hypogonadotropic hypogonadism and the effects of different modalities of hormonal treatment.
Topics: Adolescent; Adult; Analysis of Variance; Androgens; Biomarkers; Chorionic Gonadotropin; Dihydrotestosterone; Estradiol; Follicle Stimulating Hormone; Hormone Replacement Therapy; Humans; Hypogonadism; Klinefelter Syndrome; Luteinizing Hormone; Male; Middle Aged; Paris; Prospective Studies; Retrospective Studies; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome; Young Adult | 2011 |
Association of hypogonadism with vitamin D status: the European Male Ageing Study.
Topics: Adult; Aged; Cross-Sectional Studies; Dihydrotestosterone; Estradiol; Gas Chromatography-Mass Spectrometry; Humans; Hypogonadism; Immunoassay; Logistic Models; Luteinizing Hormone; Male; Middle Aged; Parathyroid Hormone; Sex Hormone-Binding Globulin; Testosterone; Vitamin D; Vitamin D Deficiency | 2012 |
Androgen initiates Sertoli cell tight junction formation in the hypogonadal (hpg) mouse.
Topics: Androgens; Animals; Connexins; Dihydrotestosterone; Disease Models, Animal; Follicle Stimulating Hormone; Humans; Hypogonadism; Male; Mice; Mice, Transgenic; Organ Size; Rats; RNA, Messenger; Sertoli Cells; Tight Junctions | 2012 |
Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues.
Topics: Aged; Androstenedione; Dihydrotestosterone; Disease Progression; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gonadal Steroid Hormones; Humans; Hypogonadism; Immunohistochemistry; Male; Orchiectomy; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Testosterone | 2013 |
Androgen receptors in human synoviocytes and androgen regulation of interleukin 1beta (IL-1beta) induced IL-6 production: a link between hypoandrogenicity and rheumatoid arthritis?
Topics: Adolescent; Adult; Analysis of Variance; Arthritis, Rheumatoid; Cells, Cultured; Dihydrotestosterone; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hypogonadism; Inflammation Mediators; Interleukin-1; Interleukin-6; Middle Aged; Probability; Receptors, Androgen; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Severity of Illness Index; Synovial Membrane | 2002 |
Plasma lipoprotein profile in the male cynomolgus monkey under normal, hypogonadal, and combined androgen blockade conditions.
Topics: Adipose Tissue; Androgen Antagonists; Androgens; Animals; Apolipoproteins B; Body Composition; Dihydrotestosterone; Drug Administration Schedule; Flutamide; Hypogonadism; Lipoproteins; Lipoproteins, LDL; Macaca fascicularis; Male; Mesentery; Orchiectomy; Testosterone | 2004 |
Perinatal testosterone surge is required for normal adult bone size but not for normal bone remodeling.
Topics: Androgens; Animals; Bone and Bones; Bone Density; Bone Development; Bone Remodeling; Dihydrotestosterone; Femur; Hypogonadism; Male; Mice; Mice, Inbred C3H; Mice, Mutant Strains; Orchiectomy; Osteocalcin; Testosterone; Tibia | 2006 |
Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men.
Topics: Adolescent; Adult; Affect; Androsterone; Cross-Over Studies; Dihydrotestosterone; Double-Blind Method; Estradiol; Humans; Hypogonadism; Injections, Intramuscular; Leuprolide; Male; Middle Aged; Radioimmunoassay; Sexual Behavior; Spinal Puncture; Testosterone | 2006 |
Development of a highly sensitive and selective UPLC/MS/MS method for the simultaneous determination of testosterone and 5alpha-dihydrotestosterone in human serum to support testosterone replacement therapy for hypogonadism.
Topics: Chromatography, Liquid; Dihydrotestosterone; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Testosterone | 2008 |
On the role of dihydrotestosterone in regulating luteinizing hormone secretion in man.
Topics: Adult; Castration; Cryptorchidism; Dihydrotestosterone; Estradiol; Humans; Hypogonadism; Luteinizing Hormone; Male; Testicular Diseases; Testosterone | 1980 |
Responses to constant infusion of LH-RH in girls with primary hypogonadism.
Topics: Adolescent; Adult; Androstenedione; Child; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Humans; Hydroxyprogesterones; Hypogonadism; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Progesterone; Testosterone; Turner Syndrome | 1980 |
Which testosterone replacement therapy?
Topics: Administration, Oral; Adult; Aged; Androstane-3,17-diol; Dihydrotestosterone; Drug Implants; Estradiol; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Testosterone | 1984 |
Mild Hypogonadotropic hypogonadism in obese men.
Topics: Adolescent; Adult; Dihydrotestosterone; Follicle Stimulating Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Obesity; Pituitary Gland; Reference Values; Sperm Count; Sperm Motility; Testis; Testosterone | 1982 |
Hormonal replacement and sexuality in men.
Topics: Adult; Age Factors; Aged; Biotransformation; Castration; Dihydrotestosterone; Dose-Response Relationship, Drug; Erectile Dysfunction; Follicle Stimulating Hormone; Humans; Hypogonadism; Libido; Luteinizing Hormone; Male; Middle Aged; Sex Characteristics; Sexual Behavior; Testosterone | 1982 |
Reassessment of the human chorionic gonadotropin stimulation test in hypogonadal males.
Topics: Adult; Chorionic Gonadotropin; Dihydrotestosterone; Estradiol; Gonadal Steroid Hormones; Humans; Hypogonadism; Male; Testosterone; Thyrotropin; Thyroxine; Triiodothyronine | 1982 |
Percutaneous absorption of 5 alpha-dihydrotestosterone in man. II. Percutaneous administration of 5 alpha-dihydrotestosterone in hypogonadal men with idiopathic haemochromatosis; clinical, metabolic and hormonal effectiveness.
Topics: Adult; Aged; Dihydrotestosterone; Double-Blind Method; Hemochromatosis; Humans; Hypogonadism; Kinetics; Male; Middle Aged; Skin Absorption | 1982 |
Single vs. multiple dose hCG stimulated Leydig cell responses in eugonadal and hypogonadal subjects.
Topics: Adolescent; Adult; Child; Chorionic Gonadotropin; Dihydrotestosterone; Estradiol; Humans; Hypogonadism; Kinetics; Leydig Cells; Male; Testosterone | 1994 |
Microphallus: eventual phallic size is dependent on the timing of androgen administration.
Topics: Animals; Dihydrotestosterone; Drug Administration Schedule; Gonadotropins, Pituitary; Hypogonadism; Immunohistochemistry; Male; Penis; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Time Factors | 1994 |
Androgen regulation of circulating insulin-like growth factor-I during puberty in male hypogonadal mice.
Topics: Androgens; Animals; Body Weight; Cross-Sectional Studies; Dihydrotestosterone; Hypogonadism; Insulin-Like Growth Factor I; Kidney; Liver; Longitudinal Studies; Male; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Organ Size; Seminal Vesicles; Sexual Maturation; Spleen; Testis; Testosterone | 1993 |
Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate--a clinical research center study.
Topics: Administration, Sublingual; Adult; Blood; Blood Cell Count; Cyclodextrins; Dihydrotestosterone; Estradiol; Gonadotropins; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Sex Hormone-Binding Globulin; Sexual Behavior; Testosterone | 1995 |
Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men.
Topics: Adolescent; Adult; Dihydrotestosterone; Drug Implants; Estradiol; Follicle Stimulating Hormone; Half-Life; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Patient Satisfaction; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 1996 |
Serum LH concentrations in hypogonadal men during transdermal testosterone replacement through scrotal skin: further evidence that ageing enhances testosterone negative feedback. The Testoderm Study Group.
Topics: Administration, Cutaneous; Adult; Aged; Aging; Analysis of Variance; Dihydrotestosterone; Estradiol; Feedback; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Sex Hormone-Binding Globulin; Statistics, Nonparametric; Testosterone; Time Factors | 1997 |
Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years.
Topics: Administration, Cutaneous; Adult; Bone Density; Dihydrotestosterone; Estradiol; Follow-Up Studies; Humans; Hypogonadism; Male; Middle Aged; Prospective Studies; Prostate; Prostate-Specific Antigen; Scrotum; Testosterone | 1999 |
Alterations in hepatic lipase and lipoprotein subfractions with transdermal testosterone replacement therapy.
Topics: Administration, Cutaneous; Adult; Dihydrotestosterone; Hormone Replacement Therapy; Humans; Hypogonadism; Lipase; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Liver; Longitudinal Studies; Male; Testosterone | 1999 |
Hypogonadism following prostate-bed radiation therapy for prostate carcinoma.
Topics: Aged; Aged, 80 and over; Dihydrotestosterone; Estradiol; Fertility Agents, Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Radiation Injuries; Testis; Testosterone | 2001 |
Effects of oral testosterone undecanoate in hypogonadal male patients.
Topics: Adolescent; Adult; Androstenedione; Dihydrotestosterone; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; Mental Processes; Middle Aged; Sexual Behavior; Testosterone; Thyrotropin-Releasing Hormone | 1978 |
Testosterone-induced inhibition of the LH and FSH responses to gonadotropin-releasing hormone occurs slowly.
Topics: Adult; Dihydrotestosterone; Dose-Response Relationship, Drug; Estradiol; Follicle Stimulating Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Pituitary Hormone-Releasing Hormones; Testosterone | 1977 |
Studies on the role of sex steroids in the feedback control of gonadotropin concentrations in men. III. Androgen resistance in primary gonadal failure.
Topics: Dihydrotestosterone; Estradiol; Feedback; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypogonadism; Kinetics; Leydig Cells; Luteinizing Hormone; Male; Testosterone | 1979 |
[Effects of longterm HCG administration on testicular function in hemodialysis patients (author's transl)].
Topics: Adult; Androstane-3,17-diol; Cell Count; Chorionic Gonadotropin; Dihydrotestosterone; Follicle Stimulating Hormone; Humans; Hypogonadism; Kidney Failure, Chronic; Long-Term Care; Luteinizing Hormone; Male; Middle Aged; Renal Dialysis; Spermatozoa; Testosterone | 1976 |
Gonadal function abnormalities in sickle cell anemia. Studies in adult male patients.
Topics: Adolescent; Adult; Androstenedione; Anemia, Sickle Cell; Dihydrotestosterone; Erythrocytes; Female; Follicle Stimulating Hormone; Growth Disorders; Hair; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Sex Characteristics; Testosterone; Zinc | 1976 |
Testosterone and 5alpha-androstan-17beta-ol-3-one (DHT) levels in man.
Topics: Adolescent; Adult; Aged; Androgen-Insensitivity Syndrome; Dihydrotestosterone; Female; Humans; Hypogonadism; Liver Cirrhosis; Male; Middle Aged; Portacaval Shunt, Surgical; Sex Factors; Testosterone | 1976 |
[Studies on plasma 5 alpha-dihydrotestosterone (author's transl)].
Topics: Dihydrotestosterone; Female; Follicular Phase; Humans; Hypogonadism; Klinefelter Syndrome; Luteal Phase; Male; Pregnancy; Pregnancy Trimester, Third; Radioimmunoassay | 1976 |
The hypothalamus and reproduction.
Topics: Acromegaly; Amenorrhea; Craniopharyngioma; Dihydrotestosterone; Estradiol; Female; Follicle Stimulating Hormone; Galactorrhea; Gonadotropin-Releasing Hormone; Gonadotropins; Half-Life; Humans; Hypogonadism; Hypopituitarism; Hypothalamus; Infertility; Luteinizing Hormone; Male; Oligospermia; Ovulation; Pituitary Neoplasms; Pregnancy; Radioimmunoassay; Reproduction; Steroids | 1975 |
Dissociated responses of plasma testosterone and estradiol to human chorionic gonadotropin in adult men.
Topics: Adolescent; Adult; Chorionic Gonadotropin; Dihydrotestosterone; Estradiol; Gonadotropins; Humans; Hypogonadism; Male; Middle Aged; Radioimmunoassay; Testosterone | 1975 |
Testosterone 5alpha-reduction in the skin of normal subjects and of patients with abnormal sex development.
Topics: Adolescent; Adult; Androgen-Insensitivity Syndrome; Androstanes; Child; Child, Preschool; Chorionic Gonadotropin; Depression, Chemical; Dihydrotestosterone; Estrogens; Female; Hirsutism; Humans; Hypogonadism; Male; Middle Aged; Oxidoreductases; Skin; Sterols; Stimulation, Chemical; Testosterone | 1975 |
Radioimmunoassay of plasma dihydrotestosterone in normal and hypogonodal men.
Topics: Adult; Age Factors; Aged; Dihydrotestosterone; Evaluation Studies as Topic; Humans; Hypogonadism; Klinefelter Syndrome; Male; Middle Aged; Oximes; Radioimmunoassay | 1975 |
[Stimulation of testicular secretion by chorionic gonadotrophin. Results in normal men and in hypogonadic patients].
Topics: Adult; Aged; Chorionic Gonadotropin; Dihydrotestosterone; Estradiol; Humans; Hypogonadism; Male; Middle Aged; Secretory Rate; Stimulation, Chemical; Testis; Testosterone | 1976 |
Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men.
Topics: Administration, Cutaneous; Adult; Aged; Dihydrotestosterone; Estradiol; Humans; Hypogonadism; Luteinizing Hormone; Middle Aged; Sex Hormone-Binding Globulin; Skin; Skin Absorption; Testosterone | 1992 |
Sublingual administration of testosterone-hydroxypropyl-beta-cyclodextrin inclusion complex simulates episodic androgen release in hypogonadal men.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Sublingual; Adult; Androgens; Androstenedione; beta-Cyclodextrins; Cyclodextrins; Dihydrotestosterone; Drug Combinations; Estradiol; Estrone; Follicle Stimulating Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; Pilot Projects; Testosterone; Time Factors | 1991 |
Testosterone replacement therapy and sleep-related erections in hypogonadal men.
Topics: Adult; Diagnosis, Differential; Dihydrotestosterone; Humans; Hypogonadism; Male; Middle Aged; Monitoring, Physiologic; Penile Erection; Sexual Dysfunctions, Psychological; Sleep Stages; Testosterone | 1990 |
Treatment of primary hypogonadism in men by the transdermal administration of testosterone.
Topics: Administration, Cutaneous; Adult; Dihydrotestosterone; Follicle Stimulating Hormone; Humans; Hypogonadism; Injections, Subcutaneous; Luteinizing Hormone; Male; Membranes, Artificial; Testosterone | 1989 |
Testosterone replacement with transdermal therapeutic systems. Physiological serum testosterone and elevated dihydrotestosterone levels.
Topics: Administration, Cutaneous; Adult; Aged; Dihydrotestosterone; Humans; Hypogonadism; Male; Middle Aged; Scrotum; Testosterone; Time Factors | 1989 |
Hypogonadism does not mediate urinary calcium loss in pituitary-grafted rats.
Topics: Calcium; Dihydrotestosterone; Estradiol; Female; Hyperprolactinemia; Hypogonadism; Male; Orchiectomy; Ovariectomy; Pituitary Gland, Anterior; Sodium; Testosterone | 1989 |
Absorption of dihydrotestosterone (DHT) after its intramuscular administration.
Topics: Absorption; Adult; Delayed-Action Preparations; Dihydrotestosterone; Half-Life; Humans; Hypogonadism; Injections, Intramuscular; Male; Radioimmunoassay | 1989 |
Transdermal testosterone therapy in the treatment of male hypogonadism.
Topics: Administration, Cutaneous; Androstane-3,17-diol; Dihydrotestosterone; Estradiol; Humans; Hypogonadism; Male; Testosterone | 1988 |
Initial trial of slow-release testosterone microspheres in hypogonadal men.
Topics: Adult; Capsules; Delayed-Action Preparations; Dihydrotestosterone; Estradiol; Humans; Hypogonadism; Male; Middle Aged; Sex Hormone-Binding Globulin; Testosterone | 1988 |
Androgen levels and sex functions in testosterone-treated hypogonadal men.
Topics: Administration, Oral; Adult; Delayed-Action Preparations; Dihydrotestosterone; Drug Combinations; Humans; Hypogonadism; Injections; Male; Methyltestosterone; Middle Aged; Sexual Behavior; Tamoxifen; Testosterone; Time Factors | 1987 |
[Depot mesterolone therapy in hypogonadism].
Topics: Adolescent; Adult; Delayed-Action Preparations; Dihydrotestosterone; Drug Evaluation; Humans; Hypogonadism; Injections, Intramuscular; Klinefelter Syndrome; Male; Mesterolone; Middle Aged; Sexual Maturation | 1974 |
Gonadotrophin-releasing hormone therapy in hypogonadal males with hypothalamic or pituitary dysfunction.
Topics: Acromegaly; Adolescent; Adult; Brain Diseases; Brain Neoplasms; Craniopharyngioma; Dihydrotestosterone; Estradiol; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Hypogonadism; Hypothalamus; Injections, Subcutaneous; Luteinizing Hormone; Male; Pituitary Diseases; Protein Binding; Puberty; Serum Globulins; Spermatogenesis; Testosterone | 1974 |
Drugs in infertility.
Topics: Anabolic Agents; Dihydrotestosterone; Follicle Stimulating Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; Methane; Testosterone | 1973 |
[Data on the hematic conversion of testosterone into dihydrotestosterone in subjects with hypogonadism].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Dihydrotestosterone; Female; Follicle Stimulating Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; Testosterone | 1973 |
Serum testosterone analysis by competitive protein binding: chromatography on silica-impregnated fiberglass and protein precipitation with ammonium sulfate.
Topics: Adult; Ammonium Sulfate; Androstanes; Blood; Chemical Precipitation; Chorionic Gonadotropin; Chromatography, Paper; Chromatography, Thin Layer; Dihydrotestosterone; Female; Humans; Hydroxysteroids; Hypogonadism; Male; Mathematics; Methods; Middle Aged; Pregnancy; Protein Binding; Testosterone; Tritium | 1972 |
Further studies on the pathophysiology of testicular feminization syndrome.
Topics: 17-Hydroxycorticosteroids; Adult; Androgen-Insensitivity Syndrome; Androstanes; Blood Proteins; Carbon Isotopes; Color Vision Defects; Dihydrotestosterone; Eunuchism; Humans; Hypogonadism; Intellectual Disability; Male; Olfaction Disorders; Protein Binding; Sex Chromosome Aberrations; Sterols; Testosterone; Tritium | 1971 |
Anabolic effect of dihydrotestosterone in testicular feminization syndrome.
Topics: 17-Ketosteroids; Adult; Androgen-Insensitivity Syndrome; Body Weight; Castration; Cell Nucleus; Color Vision Defects; Creatinine; Dihydrotestosterone; Estrogens; Eunuchism; Humans; Hypogonadism; Intellectual Disability; Male; Nitrogen; Olfaction Disorders; Phosphates; Receptors, Drug; Sex Chromosome Aberrations; Stimulation, Chemical; Testosterone | 1971 |
Studies on testosterone metabolism in human subjects with normal and pathological sexual differentiation.
Topics: 17-Ketosteroids; Adult; Androgen-Insensitivity Syndrome; Androstanes; Androsterone; Carbon Isotopes; Chorionic Gonadotropin; Dihydrotestosterone; Disorders of Sex Development; Glucuronates; Humans; Hypogonadism; Hypopituitarism; Male; Middle Aged; Sulfates; Testosterone; Tritium; Turner Syndrome | 1968 |